The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: a multicenter, cohort study.

Autor: Aljuhani O; Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia., Al Sulaiman K; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; Saudi Critical Care Pharmacy Research (SCAPE) Platform, Riyadh, Saudi Arabia., B Korayem G; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia., Alharbi A; Pharmaceutical Care Department, King Abdulaziz Medical City, Jeddah, Saudi Arabia., Altebainawi AF; Pharmaceutical Care Services, King Salman Specialist Hospital, Hail Health Cluster, Ministry of Health, Hail, Saudi Arabia.; Department of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia., Aldkheel SA; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia., Alotaibi SG; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia., Vishwakarma R; Norwich Medical School, University of East Anglia, Norwich, UK., Alshareef H; Department of Pharmacy Practice, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia., Alsohimi S; Pharmaceutical Care Services, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia.; Pharmaceutical Care Services, King Abdulaziz University Hospital, Jeddah, Saudi Arabia., AlFaifi M; Pharmaceutical Care Department, King Saud Medical City, Riyadh, Saudi Arabia., Al Shaya A; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia., Alhaidal HA; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Alsubaie RM; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Alrashidi H; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Albarqi KJ; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Alangari DT; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Alanazi RM; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Altaher NM; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Al-Dorzi HM; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; Intensive Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

Publikováno v: Renal failure [Ren Fail] 2023; Vol. 45 (2), pp. 2268213. Date of Electronic Publication: 2023 Oct 23.